Article Reprints
eMarketing/Internet The following Pharma Marketing News reprints and case studies relating to “eMarketing” – the use of the Internet to market to consumers and/or physicians using public Web site or e-mail – are available. You might also be interested in the following categories for additional reprints relating to Marketing Techniques and Tools:
Special Supplement Social Media Pharma Marketing
Is it time for the pharmaceutical industry to take the advice of some of its critics and use the new “social media” tools available to it and extricate itself from its moribund situation of declining ROI?
These new tools — lumped under the heading “social networking” or “Web 2.0 — are big topics of discussion at many pharmaceutical marketing conferences. The question is, will pharma marketers embrace them, learn how to use them, and will they see benefits?
This collection of Pharma Marketing News articles, blog posts, and survey results provides you with an excellent introduction to the many issues involved in social media pharma marketing.
Order and pay for this Special Supplement now using your credit card…
ONLY $29.95
Download PDF file immediately after paying:
If you wish to pay by check or credit card off-line, please use:
Printable Order Form
Many experts believe that pharma eMarketing is at a tipping point and that pharmaceutical companies are poised to shift substantial ad spending from TV and other media to the Internet.
The selection of articles in this Special Supplement to Pharma Marketing News was chosen to give you a better perspective on pharma eMarketing. Included are real world case studies that illustrate the advantages of eMarketing such as depth of information, interaction, relationship building and superior customer engagement.
Order and pay for this Special Supplement now using your credit card…
ONLY $29.95
Download PDF file immediately after paying:
If you wish to pay by check or credit card off-line, please use:
Printable Order Form
This article presents key takeaways from the FDA hearing, a synopsis of the presentations made by John Mack, Publisher, Pharma Marketing News, at the hearing, a review of Ignite Health’s study regarding effectiveness of sponsored links, and the next steps in the process of issuing guidance.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
The Absolute, Relative, and Incremental ROI of DTC e-Marketing
The debate surrounding the strategic and economic value of having an online DTC strategy rings loud and clear at most global pharmaceutical companies today. In general, the key questions are where and how the online strategy creates disproportionate and sustainable value for the brand. This article focuses on the power of the product Web site as a conversion tool and illustrates how the Web strategy fits into the overall marketing continuum – from initial engagement all the way to loyalty marketing.
Read this article now. It’s FREE…
Download PDF fileAccountability for Pharma Content on Social Media Sites
A substantial portion of drug industry comments submitted to the FDA was devoted to how pharmaceutical companies should be held accountable for a communication about its product(s) and how much control they exert over activities on the Internet and social media.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Also see:
- Industry and Consumer Advocates Square Off Regarding Social Media
- Overcoming Space Limitations in Social Media
- Solving the Social Media Adverse Event Reporting Problem
- Special Report: FDA’s Regulation of Drug & Device Promotion via the Internet & Social Media
Applying FDA Marketing Regulations to Internet Promotions
Preeti Pinto, M.S., Senior Director Promotional Regulatory Affairs, AstraZeneca, provides insight on the regulatory actions taken by the FDA with respect to online DTC marketing by pharmaceutical companies. She summarizes the most commonly cited violations found on pharmaceutical company web pages.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Are Pharma Bloggers Biased Against the Industry?
How supportive or critical are individual blogs in the pharma blogosphere and is there an overall bias one way or the other?
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
A Case for Pharmaceutical Web Site Accreditation
There are thousands of health Web sites on the Internet. Accreditation is not an appropriate path for all these sites to take, but for those sites that can afford it and that meet rigorous standards for quality and accountability, accreditation can help distinguish them from their competitors and increase consumer trust. Pharmaceutical sites focusing on consumers, in particular, stand to benefit.
Click Here for Full Text – FREE! (pdf).
Can Health Web Sites Improve Compliance?For various reasons, it is hard to find a conclusively documented answer to a seemingly simple question: do interactive health education media improve patients’ health practices? In fact, a recent high-profile report attempted to answer that question and got it wrong: procedural flaws led them to an unjustified conclusion. The problem lies in seeking a broad general picture. More appropriate is to focus on the specific patient population, the distinct behaviors to be changed, and the particular tactics employed.
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
cDetailing: Addressing the Consumer Education Gap
Steve Smith, Editor-in-Chief of Medsite has reengineered his company’s eDetailing line to create engaging interactions crafted around effective methods to engage, inform, and educate adults. Now he has tapped this experience to design the company’s first Consumer Detailing (“cDetailing”) product, which is a novel rich-media online consumer disease education and drug information program.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
The Changing Landscape of Physician Interactions
Pharmaceutical companies are under increasing pressure to reduce costs, speed the time-to-market for new products and ensure that physicians are informed and educated about their products.
MERGE Rx recognizes this need and offers a new generation of Web-enabled software that helps pharmaceutical companies manage physician interactions — including key opinion leader (KOL) management, phaseIV trials, and eDetailing — from a single, secure and scalable access point.
Topics and issues covered include:
- Eight Great Ways to Improve Interactions
- Multi-Channel Non Personal Interactions
- Personalization
- Key Opinion Leader Management
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
Closed-Loop Marketing
This article is a review of an industry conference presentation that focused focused on leveraging eDetailing for effective closed-loop marketing campaigns.
Order and pay for this reprint now using your credit card…
ONLY $9.95Download PDF file immediately after paying:
Closed-Loop Patient Education: MedTera and HealthPrize Team Up to Improve Medication Adherence & Health Outcomes
MedTera recently partnered with HealthPrize Technologies, a web-based software company that motivates people to fill and stay on prescription medications, to bring together MedTera’s online and offline educational resources and HealthPrize’s online, interactive platform to educate people about their chronic diseases and incentivize them for taking their medications as prescribed.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
The Coming Pharma Marketing Recession
This article presents opinions and evidence that there is a slump in pharma marketing spending and provides some tips to vendors and ad agencies to help them the slump.
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
Consumer Use of the Internet for Health: Whose Numbers Do You Believe?
This article includes DATA and an analysis of methodologies of various online consumer market research studies to help you understand how to apply these data to your online marketing campaigns.
Click Here for Full Text – FREE! (pdf).
Data Mining in the Deep, Dark Social Networks of PatientsIf pharma marketers wish to tap into closed online patient communities that are rich sources of information, they need to pay careful attention to the rules lest they suffer the consequences to their reputations.
Topics include:
- The Dark Depths of “Closed” Patient Communities
- Patient Information for Sale
- Pharma Trolls Social Media
- Transparency, Openness and Privacy
- Beware of Stolen “Copper”
- The ePatient Perspective
- What Are Your Social Media Principles?
- Aligning Your Message with Patient Needs
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
DocCheck: Das Portal
This article describes the services offered by DocCheck and specifically focuses on the portal’s market research and physician-targeting capabilities, which any pharmaceutical marketer wishing to do professional marketing in Germany should know more about. Includes sections:
- Day of the Portals
- Universal Physician Password
- eDetailing in Europe
eDetailing Strategies for a Higher Physician Response
Most pharmaceutical firms have piloted eDetailing programs and scaled them successfully. However, although Traditional eDetailing has been around for at least 5 years, marketers must expand the definition of eDetailing. To this end Croom offers a Best Practice Guide for eDetailing to help pharma marketers optimize the reach and impact of eDetailing.
Before you buy this reprint, take a look at the Special Supplement: eDetailing, which contains this reprint and other articles on eDetailing and ePromotion to physicians.
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
eDetailing: Yesterday, Today and Tomorrow
eDetailing proponents, inside pharma companies and outside, use survey data to justify their arguments for greater spending on eDetails. In some cases, however, the numbers seem to show confusing trends and even may suggest that eDetailing may not be all that it’s cracked up to be.
Order and pay for this reprint now using your credit card…
ONLY $9.95Download PDF file immediately after paying:
e-Inertia Plagues the Pharma Industry
To make sense of current estimates about pharma spending online and understand where it may be heading in the future, Pharma Marketing News recently hosted a Pharma Marketing Roundtable discussion of the issues. This article summarizes that discussion.
ONLY $4.95
Download PDF file immediately after paying:
E-mail Marketing Best Practices for Pharma
Several recent surveys indicate that pharmaceutical companies will spend more money on e-mail marketing to consumers in 2005 (see “DTC in 2005: Can You Teach Old Dogs New Tricks?“). Perhaps they should also spend some money and time to ensure that their e-mail campaigns adhere to emerging best practices with regard to privacy, HIPAA, SPAM, and permission-based marketing.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
e-Marketing at the Point of Care
Pharmaceutical marketing strategies are evolving more rapidly than any other time in history. The traditional detail-based marketing model is being challenged by physicians’ ever-growing time pressures and lack of time for sales reps.
Given these challenges, most pharmaceutical companies are committing some level of marketing resources to e-promotion, including e-detailing and e-CME initiatives. This article reviews e-prescribing offerings of vendors like Allscripts Healthcare Solutions and ScriptRx, Inc.
Click Here for Full Text – FREE! (pdf).
ePrescribing: What Role Should Pharma Play?
A panel entitled What Role Should Pharma Play in ePrescribing and the Point-of-Care? at a recent ePharma Summit conference held in Philadelphia, PA, discussed the issues facing pharmaceutical companies as electronic prescribing (ePrescribing or eRx) threatens to upset the “balance of power” between physicians, pharma companies, and payers at the point-of-care.
ePrints NRx for Physician Detailing
This article describes and summarizes the features and benefits of the Reprints Desk’s ePrints NRx solution — a new scientific article collection service that simplifies the re-use of PDFs by medical marketers, brand managers, and sales professionals.
Topics include:
- Physicians Value Support Services
- Journal Articles Highly Valued by Docs
- ePrints NRx Solution
- Managing Digital Rights
- Solving Persistent eChallenges
- Good Reprint Practices
- ePrints NRx & Closed-Loop Marketing
- Case Study: Web Portal Integration for Immediate Article ePrint Downloads
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
Ethical Online Practices Build Consumer Trust
Although pharmaceutical firms claim they are not required to comply with regulations enacted under the Health Insurance Portability and Accountability Act of 1996, using HIPAA as a model for online policy may help drug companies improve their public images, build trust with consumers and, ultimately, sell more products
Click Here for Full Text – FREE! (pdf).
European Compliance Not Only Possible, But Leading EdgeAs US pharmaceutical companies search for best practices to battle patient drop-off, their European counterparts have overcome Byzantine regulations and reduced margins to implement strikingly effective compliance programs directly to consumers.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
The European eMarketing Scene: Desperately Seeking Strategy
The pharmaceutical industry is struggling to develop an eMarketing strategy in Europe, which is comprised of many relatively small markets (the member countries of the EU) having significant cultural and language differences.
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
European Online Marketing Survey Results
This article presents selected results from a survey of pharmaceutical experts on eDetailing and Online Marketing conducted in 2005 by eyeforpharma, MediQuality, and PharmiWeb Solutions.
Click Here for Full Text – FREE! (pdf).
The Evolving Impact of Anti-Spam Legislation on Online MarketersIn the last year the FTC has issued regulations that set forth additional requirements under the federal CAN-SPAM act that you should be aware of. Hilary M. Wandall, Esq., CIPP, Director, Corporate Legal/Merck Privacy Office, Merck & Co., Inc., summarized these regulations in a recent ePharma Summit presentation in Atlantic City, NJ.
Click Here for Full Text – FREE! (pdf).
Eyes on the Adherence Prize: How HealthPrize Uses Financial Incentives and Fun to Change Patient BehaviorThis article provides details about the HealthPrize’s innovative, compelling approach to solving one of pharma’s most perplexing puzzle: how to improve medication adherence. Included is a summary of a Pharma Marketing Talk podcast interview of Tom Kottler, CEO, and Katrina S. Firlik, M.D., Chief Medical Officer, HealthPrize.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Fast Start to Customized ePromotion and eLearning Physician Programs
There is a broad spectrum of online promotional and educational opportunities that pharmaceutical companies have at their disposal to interact with, inform, and influence physicians. Lathian Systems, a provider of online marketing and sales solutions, offers these and more in its Spectrum of Solutions for life science companies.
Four Useful Lessons Pharma Can Learn from the Pfizer Facebook HackPfizer’s US corporate Facebook page was “hacked” by some ‘Kiddies.’ What should the industry learn from this experience?
Read this article now. It’s FREE…
Read It Online HereThe Future of eDetailing
This article reviews a presentation made by David Ormesher, CEO of closerlook, inc. at the recent CBI eDetailing Conference in which he said, The future of eDetailing is physician relationship management. The benefits of creating long-term relationships include brand loyalty, detailed customer intelligence and sales integration with the field force.
Click Here for Full Text – FREE! (pdf).
Got Game? Online Pharma AdvergamingWhile advergaming seems to work for the consumer package goods industry, will it also work for pharmaceuticals?
Topics covered include:
- The Game: Give Your Legs a Rest
- Not Medical Advice; Also Not Educational!
- It May Fly in Battlecreek, But Not in Raritan!
- Rx Drugs Require More Than Branding
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Helping Pharma eMarketing “Grow up”
eMarketing Benchmarks
Pharmaceutical marketers are continually challenged by their superiors to quantitatively measure the return on investment (ROI) of their campaigns. This is especially true for their eMarketing initiatives.
So, how do you know which online tactics are giving you the best return on your investment? To get started it is helpful to compare and contrast your own online strategy’s performance against competitive and perceived “best-of-class” tactics to evaluate the effectiveness of online programs, emulate effective strategies, and establish best practices. In other words, you need some eMarketing benchmarks.
This article summarizes a Pharma Marketing Talk conversation with Carolina Petrini, SVP, Marketing Solutions, comScore, regarding her company’s consumer e-marketing effectiveness benchmarks for the pharmaceutical industry.
Topics and issues covered include:
- eMarketing Benchmarks
- Methodology
- Prospects vs. Patients
- Favorability Benchmarks
- Conversion/New Starts Benchmarks
- Change in Norms Over the Years
- What about Web 2.0?
- How to Use the Benchmarks
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying: How Readable, Credible & Useful are Pharma Blogs?
This article presents the compllete results from the first ever survey of The Pharma Blogosphere in which blog readers evaluate 22 different pharma-related blogs on the basis of readability, credibility, usefulness, and bias.
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
How to Manage the Online Conversation
This article presents a summary of a conversation with Jenna Woodul, LiveWorld’s EVP and Chief Community Officer, about how pharma companies can manage their social media interactions using technology and credentialed participants.
Click Here for Full Text – FREE! (pdf).
The iPad as a Pharma Marketing PlatformThis article summarizes how the iPad is currently being used by the pharmaceutical industry, how it is being adopted by physicians, and what the roadblocks are to using it for eDetailing.
Topics include:
- iPad – What’s It Good For?
- The iPad as a Pharma Marketing Platform
- GoMeals
- More Consumer Apps
- Opening Doors to Physicians
- iPad for eDetailing
- DrChrono.com Featured on Pharma Marketing Talk Radio
- Is It Just Another Tablet Device?
- Does No Flash Mean No eDetailing?
- iAds for Pharma?
- Is Pharma Blocking or Supporting iPad Use by Sales Reps?
Many Physicians Plan to Buy It
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
The Impact of eDetailing: Will it Complement, Replace, or Become Integrated with the Sales Force?
The number of pharmaceutical sales representatives has increased sharply in recent years. More than 90,000 representatives compete for the attention of 650,000 practicing physicians, only 125,000 of whom are top-tier prescribers. Some people, maybe physicians most of all, hope that online detailing (eDetailing) will reduce the number of office visits from all these pharmaceutical sales representatives chasing after the same docs. This article reviews a presentation on this provocative topic made by David Hauben, Director of eBusiness at Aventis Pharmaceuticals.
Click Here for Full Text – FREE! (pdf).
Industry and Consumer Advocates Square Off Regarding Social MediaThis article presents an overview of the types of organizations that submitted comments versus those that made presentations at the November 2009 public hearing. It also includes general comments from the pharma industry regarding the process by which the FDA should regulate the Internet and social media. Also presented in this article are the comments submitted by consumer advocates and individuals who generally supported more strict regulation across the board.
Click Here for Full Text – FREE! (pdf).
Also see:
- Overcoming Space Limitations in Social Media
- Accountability for Pharma Content on Social Media Sites
- Solving the Social Media Adverse Event Reporting Problem
- Special Report: FDA’s Regulation of Drug & Device Promotion via the Internet & Social Media
Many pharmaceutical companies are currently absorbing their e-business units and personnel back into the brand teams. This may be a glass is half-empty versus half-full situation. Someone who looks upon the glass as half-full is Bruce W. Bunyan, Senior Director & General Manager at Aventis Behring, the therapeutic proteins business of Aventis. This article includes a case study based on Bunyan’s experience on how Aventis Behring brought together the online and offline marketing mix within his company. He frankly discussed the obstacles he faced and claimed “he learns more from his mistakes than from his successes.” It is obvious, however, that Aventis Behring is on the right track in overcoming the challenges.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Intelligent Online Sampling Strategies
New online strategies have made eSampling a tool for significantly expanding targeted physician and sample coverage. Applications include accelerating new product uptake, efficiently maintaining physician coverage for mature brands, covering hard to reach physicians and driving patient demand.
Before you buy this reprint, take a look at the Special Supplement: eDetailing, which contains this reprint and other articles on eDetailing and ePromotion to physicians.
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
The Internet and CME
Despite the fact that physician usage of the Internet has increased over the past few years, solid evidence for the reasons they access the Internet or, more importantly, if the knowledge they gained from online CME presentations has any impact on their practice is still largely unknown.
Let’s Respond to FDA’s Questions Regarding Its Regulation of Social MediaOn Monday, September 21, 2009, the FDA published a notice in the Federal Register calling for a public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools.
The FDA is requesting the public to submit comments to a series of specific questions, which are included in a new survey created by Pharma Marketing Network/News. Let’s use this survey to help educate the FDA on the issues.
Click Here for Full Text – FREE! (pdf).
Leverage Health Beliefs to Develop Effective Online Compliance ProgramsAccording to a Jupiter survey, consumers don’t manage their health online because they have low confidence in their ability to use online health resources to improve their health. Pharmaceutical marketers must leverage health beliefs and models to design comparatively more effective adherence-related online marketing programs.
Topics covered include:
- Learn how self-efficacy predicts online consumers’ health-related behavior
- Define your online strategy and prioritize spending on online marketing tactics
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
Measuring Consumer Sentiment About Prescription Drugs
At a recent Pharma Marketing Talk podcast, John Mack spoke with Mark DePaoli, life sciences analyst at BrandIntel, an online information service, about mining CGC to evaluate consumer sentiment about pharmaceuticals. This article summarizes that discussion and presents a case study analysis comparing consumer sentiment of Botox vs. Restalyne.
Topics covered include:
- The CGC/UGC Landscape – some statistics
- Case Study: Botox vs. Restalyne
- Impact of Advertising on CGC
- Monitoring Adverse Events in Conversations
Order and pay for this reprint now using your credit card…
ONLY $9.95Download PDF file immediately after paying:
Measuring & Communicating eSuccess
Strategy First, YouTube Later… Maybe
This article is a review of a presentation by Aaron Uydess, Senior eMarketing Manager at Novo Nordisk, made at Eye for Pharma’s 3rd eCommunication and Online Marketing Summit held October 23-24, 2008, in Boston, Massachusetts. Uydess presents a best-in-class approach to developing online plans that align with strategy, reduce silos, and measure and merchandise digital strategies across a pharmaceutical marketing organization.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Medical Device Marketing: Worlds Apart from Rx Drug Marketing
Medical device marketing is different than Rx drug marketing, which is something attendees of the recent PharmaMed Marketing & Media Conference hosted by Med Ad News learned.
This article summarizes a presentation from that conference and discusses how medical device marketing to consumers and physicians is different than Rx drug marketing. While some device marketing campaigns take a page from the Rx arena, there are difficulties and roadblocks ahead and these are also summarized in this article.
Order and pay for this reprint now using your credit card…
ONLY $9.95Download PDF file immediately after paying:
Merck Rejiggers Its Marketing Mix
Adam Schechter, President of Merck US Human Health, made this statement not long ago at a Goldman Sachs healthcare conference: ‘Industry must embrace new ways of engaging physicians on their terms.’
Topics covered include:
- Merck to Slash Field Force?
- Consumer Media Consumption Habits vs. Media Spend (Google chart)
- Customer Focus Means More Technology
- Engaging Customers on Their Terms
- Impact vs. Risk Analysis of Physician Marketing Channels (chart)
Order and pay for this reprint now using your credit card…
ONLY $9.95Download PDF file immediately after paying:
Midwestern eMarketing Values
On the Internet it’s still about content, content, content. Some may consider this old-fashioned. But Siren Interactive, a midwestern interactive eMarketing firm, believes that valuable Internet content is a prime component to an effective eMarketing strategy for pharmaceutical companies.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Moderation Best Practices for Pharma Social Networks
This article presents a summary of results from a recent survey of readers and other experts regarding pharma social media moderation best practices.
Order and pay for this reprint now using your credit card…
ONLY $9.95Download PDF file immediately after paying:
The New Rules of Marketing & PR
The pharmaceutical industry must find ways to utilize the new media tools that other industries use while ensuring compliance with FDA regulations. The good news is we can! The author summaries the content of the book and offers practical guidelines for the pharma marketers.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Online CME – A Glass Half-Full or Half-Empty?
This article looks at data regarding online CME – number of physicians doing CME online, etc. It also includes a case study of a popular pharma-sponsored online CME program, which highlights the necessary ingredients for success.
Online and Offline Professional and Consumer MarketingShort summaries from the Pharmaceutical Marketing Global Summit provides information about how pharma marketing practices need to evolve.
Click Here for Full Text – FREE! (pdf).
Overcoming Space Limitations in Social MediaThis article presents a summary of comments to FDA from the drug industry addressing regulatory concerns when using social media tools associated with space limitations or tools that allow for real-time communications to present product information.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Also see:
- Industry and Consumer Advocates Square Off Regarding Social Media
- Accountability for Pharma Content on Social Media Sites
- Solving the Social Media Adverse Event Reporting Problem
- Special Report: FDA’s Regulation of Drug & Device Promotion via the Internet & Social Media
Paid Inclusion: Too Hot for Pharma Marketing?
This article summarizes the issue of paid inclusion and presents results of the recent online Pharma Search Engine Marketing Survey.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Patient Detailing at the Point of Care
Return on DTC investment is decreasing and in the post-Vioxx marketing environment in which pharma marketers find themselves, there is a call for less advertising and more education. There are several new strategies and solutions available to pharmaceutical marketers that are designed to increase the education quotient of pharma marketing communications. One such solution is wireless Webpad developed by Phreesia for deployment in doctors’ offices.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Personalized e-Marketing – How can you create and profit from a customer’s lifetime experience?
Instead of talking about CRM (Customer Relationship Management), Philippe Barzin, former Director of Connectivity at Johnson & Johnson, focused on HRM or “Healthcare Relationship Management.” While CRM focuses on a single customer at any one point in time, HRM focuses on supporting the customer across multiple channels – Web, email, call center, field visits – and over a lifetime. Considering the physician customer first, Barzin cited research showing that physicians value many sources of contact with pharma companies and actually find online sources less valuable than offline! To demonstrate the effectiveness of “customer-oriented surround marketing” and personalization, Barzin used BabyCenter, a J&J consumer-focused web site, as a case study.
Click Here for Full Text – FREE! (pdf).
The Pharmaguy Next DoorJohn Mack, a.k.a. pharmaguy on Twitter, answers questions about his background and provides his opinions on how pharmaceutical companies will use social media in the future.
Click Here for Full Text – FREE! (pdf).
Pharmaguy’s Twitter Followers: What Do They Want and How Is It Relevant to You?Pharmaguy (aka John Mack) now has over 4,900 (as of November, 2009) followers and these followers are probably the same followers you’d like to have if and when you get involved in Twitter. But hurry! Breaking in as a power user may be difficult. Research shows a virtuous cycle may exist, making popular users ever more popular.
This article summarizes the findings of a survey of over 400 of @pharmaguy’s followers. The results will give you a better idea why people interested in the pharmaceutical industry use Twitter and what they expect to get out of it.
Click Here for Full Text – FREE! (pdf).
Pharma Marketing Stuck in Web 1.5In this guest article, author Richard Meyer, Senior eMarketing Manager, Medtronic, summarizes some of the key findings of the recent eMarketer report ‘Pharmaceutical Marketing Online: Stuck in Web 1.5.’
Topics covered include:
- The CGC/UGC Landscape – some statistics
- Case Study: Botox vs. Restalyne
- Impact of Advertising on CGC
- Monitoring Adverse Events in Conversations
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Pharma Online Spending
An Interview with eMarketer Senior Analyst Lisa Phillips.
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
Pharma, Physicians, and Sermo: A Social Media Win-Win-Win!
This article provides an overview of Sermo’s new Client Center and summarizes a Pharma Marketing Talk podcast interview of with Daniel Palestrant, Sermo’s Founder and Chief Executive Officer.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Pharma’s Image Conundrum
In this guest article, Carla Stratfold, CEO at OnRequest Images, presents several key learnings and best practices that pharmas can follow when building brand and consumer loyalty.
Order and pay for this reprint now using your credit card…
ONLY $9.95Download PDF file immediately after paying:
Pharma’s Social Media Marketing Readiness Score
This article summarizes the aggregate findings of the Rate Your Social Media Marketing Readiness survey and presents the average scores against which you can compare your own score.
Order and pay for this reprint now using your credit card…
ONLY $9.95Download PDF file immediately after paying:
Pharma’s Plodding Approach to eMarketing
This article, written by health communications veteran, Harry Sweeney, is a frank assessment of the pharmaceutical industy’s plodding approach to e-communication and e-marketing based on a review of a recent industry conference.
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
Pharma’s Social Media Working Group
This article reviews the Who, What, and Why of Pharma’s Social Media Working Group (SMWG) based on a conversation with Mark Gaydos, Senior Director, U.S. Regulatory Affairs Marketed Products at sanofi-aventis, and Cynthia Phillips, Sr Dir Labeling and Promotional Compliance at Millennium Pharmaceuticals. Also covered is an analysis of comments the SMWG submitted to the FDA on how pharmaceutical companies should handle off-label and adverse event posts made on social media sites owned or sponsored by them.
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
Pharma Twitter Pioneers Recognized
More and more pharmaceutical company employees are using Twitter. Pharmaguy is looking at pharma employees who have personal Twitter accounts, how they use these accounts, who follows them and whom they follow, and how influential they are. This article is an introduction to the first round of members of this group.
Read this article now. It’s FREE…
Download PDF filePrescription Drugs and the Health 2.0 Opportunity
The eDrugSearch.com Community
eDrugSearch has expanded its mission by unveiling its own Health 2.0 venture: the eDrugSearch.com Community, which is a new social network for prescription drug consumers. The eDrugSearch.com Community hopes to help members make choices that save them money, and keep them safe, when buying drugs online.
This articles reviews some of the features of this new Health 2.0 Web site.
Topics and issues covered include:
- Health 2.0 Defined
- Strangers Sharing Stories
- Drug Ratings & Reviews Section
- Should Pharma Marketers Participate?
Order and pay for this reprint now using your credit card…
ONLY $2.95Download PDF file immediately after paying: Proactive e-Marketing Plan
Pharmaceutical companies can effectively implement e-marketing programs through strategic planning and by simply augmenting their traditional sales force, suggests Devin Paullin, vice president of operations at Physicians Interactive. Paullin outlines a 12-month strategy in which firms can proactively target physicians using electronic tools, or e-tools. He recommends that firms use traditional promotion solutions and modify those solutions using e-initiatives.
Click Here for Full Text – FREE! (pdf).
Product Branding, e-Marketing May Be UnderutilizedStrengthened pharmaceutical branding and increased utilization of online marketing tools can have a significant impact on the revenue and market value of pharmaceutical firms, according to a presentation by Bill Trombetta, professor of pharmaceutical strategy and marketing at The Erivan K. Haub School of Business at St. Joseph’s University.
Click Here for Full Text – FREE! (pdf).
Quality of Pharma-sponsored Health Information on the InternetWith all the bad press recently about marketing directly to consumers and privacy concerns, perhaps it is time for the pharmaceutical industry to self-regulate marketing to consumers as well, especially via the Internet. What is the attitude of pharmaceutical professionals regarding the quality of pharma-sponsored health information on the Net? Does the industry perceive a problem in this area? To help answer this question, an online survey – Quality of Pharma-Sponsored Health Information on the Internet – was performed during the month of January, 2003. The results are summarized in this article.
Click Here for Full Text – FREE! (pdf).
Ready or Not: Gearing Up for the Expansion of ePrescribingIn a keynote address at a recent ePharma Summit conference held in Philadelphia, PA, Kevin Hutchinson, CEO and President of SureScripts, a company founded by the National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association, looked at the changing landscape and inevitability of electronic prescribing (ePrescribing or eRx) and the implications and opportunities for the pharmaceutical industry.
SPECIAL! Includes: Pfizer’s Principles for Assuring Quality of Care by Electronic Prescribing Systems
Order and pay for this reprint now using your credit card…
ONLY $2.95Download PDF file immediately after paying:
Real Patient Testimonials
This article discusses the potential pitfalls, regulatory issues, and best practices regarding the use of real patient testimonials based on comments collected from a recent survey of readers and other experts.
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
Sales Effectiveness Meets eMarketing
Steve Woodruff, Founder and Principal Consultant of Impactiviti, and John Mack team up to review eyeforpharmas Sales Effectiveness conference, which was co-located with the eCommunication & Online Marketing Conference.
Click Here for Full Text – FREE! (pdf).
Search Advertising Options for PharmaIn this article, Julie Batten, eMarketing Manager at Klick Pharma discusses pharma’s options for search marketing in this period between the FDA public hearing and when the much anticipated draft and final guidance on the issue is published.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Searching for Answers on Search Engine Marketing?
Yahoo’s record earnings and Google’s IPO announcement are hot financial stories, but they also herald an important trend that is changing the way marketers think about the interactive channel. Search Engine Marketing, also known as SEM or Search, is one of the fastest-growing e-marketing strategies today. The author covers SEM techniques such as Paid Search, Paid Inclusion, and Natural Search, and suggests that to stay ahead, companies must develop sophisticated content strategies to win the war of visibility.
Click Here for Full Text – FREE! (pdf).
Social Communications in Healthcare: Summary of Roundtable Discussions
At the Social Communications in Healthcare conference hosted by the Business Development Institute in NYC on July 23, 2009, there were so many people live Tweeting the case study presentations that it’s hardly worth the effort to summarize these presentations after the fact. You can find a good summary–if only in dozens of 140-character packets–on Twitter.
An excellent gauge of the state of social communications in healthcare may be had from summaries of the round table discussions moderated by experts after the case study presentations. After a short introduction, this article provides several summaries written by the roundtable discussion leaders themselves
Order and pay for this reprint now using your credit card…
ONLY $9.95Download PDF file immediately after paying:
Social Media Leaders Wanted
This article reviews the results of Pharma Marketing News’ ‘What’s Your Social Media Implementation Plan?’ survey and announces the details of the Pharmaguy Social Media Pioneer Award.
Click Here for Full Text – FREE! (pdf).
Social Media & the Truncated News PyramidPR people are used to issuing press releases to a few journalists at the top of the traditional news pyramid. When the top was blown off by the social media revolution, these professionals had no proven mechanism by which to reach the many thousands of bloggers at the BOTTOM of the pyramid — until now.
Click Here for Full Text – FREE! (pdf).
Social Media Adverse Event Reporting Safe HarborsThis article presents ideas for regulatory ‘safe harbors’ under which pharmaceutical companies would be relieved of the responsibility of monitoring social media for adverse events. Includes a detailed summary of responses to the survey ‘FDA Regulation of Drug & Device Promotion via the Internet & Social Media’ regarding social media adverse event monitoring, processing, challenges, and uncertainties.
Order and pay for this reprint now using your credit card…
ONLY $9.95Download PDF file immediately after paying:
Solving the Social Media Adverse Event Reporting Problem
Many presenters at FDA’s November 2009 public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools addressed this problem and offered solutions. Comments submitted to the FDA after the meeting offer more details, which are reviewed in this article.
Click Here for Full Text – FREE! (pdf).
Also see:
- Industry and Consumer Advocates Square Off Regarding Social Media
- Overcoming Space Limitations in Social Media
- Accountability for Pharma Content on Social Media Sites
- Special Report: FDA’s Regulation of Drug & Device Promotion via the Internet & Social Media
Translate Industry Trends into the Optimal Promotional Strategy
This is a summary of a recent presentation by David L. Stern, Vice President of Marketing for Metabolic and Endocrinology at Serono, Inc. Stern spoke from a marketer’s perspective about recent trends in the pharmaceutical industry and how to address them by developing better marketing programs.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Use of Behavioral Targeting by Pharma Marketers
This article summarizes the results of a survey designed to answer the questions: Should the pharmaceutical industry adopt similar self-regulatory principles that were established by media and marketing trade associations to protect consumer privacy when employing behavioral targeting, Should pharma marketers use behavioral targeting at all?, If they do use it, when is it appropriate?
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
Use of Social Media for Health Purposes in the EU
This article is a summary of the EPG Health Media (part of the IMR International Group) market research report ‘Social Media and Healthcare,’ which examines how European doctors, patients/consumers and pharma engage (and seek to engage) with each other.
The View From ePharma Summit: Practicing What Was Being Preached!
This article is a compilation of summaries of presentations made at the 2009 ePharma Summit. Included are highlights posted to the ePharma Summit and other blogs during the conference and insights on epharma marketing issues provided by several conference speakers and attendees.
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
Web 2.0 Pharma Marketing Tricks for Dummies
Pharmaceutical marketers are having a field day pushing the envelope on the Internet and especially in the social networking, Web 2.0 arena — the new WILD, WILD WEST of the Internet. Many, however, are getting caught trying to perform the ‘tricks of the trade.’ With just a little bit of guidance and tips from the masters, you can perform these tricks WITHOUT getting caught!
Topics and issues covered include:
- Consumer-Generated Content – some data
- Why Neither the FDA nor PhRMA Will Be the Wiser
- HealthTrain, the Open Healthcare Manifesto
- The So-called “One-Click Rule”
Read this article now. It’s FREE…
Download PDF fileA Web-based Therapy Management Program
Cedric Tuck-Sherman, director of eBusiness for Baxter BioScience, discussed his company’s experience with creating and managing a web-based therapy management program for chronic diseases during a recent Patient Persistence, Compliance and Education seminar sponsored by EyeforPharma.
Order and pay for this reprint now using your credit card…
ONLY $4.95Download PDF file immediately after paying:
What If There Were No Rules in Pharma Marketing?: Be Sure Not to Cut Off the Ends of Your Ham
What If There Were No Rules in Pharma Marketing? There’s no FDA, no DDMAC, no FTC. Your company guidelines and rules don’t exist and your regulatory and legal teams have been disbanded. It’s a free-for-all and there are no rules. The question is: what would you do?
Order and pay for this reprint now using your credit card…
ONLY $6.95Download PDF file immediately after paying:
What You Need to Know About the “CAN-SPAM” Law
Although the CAN-SPAM law is often portrayed as a white knight that will save us from dastardly e-mail spammers and pornographers, many of its provisions cover all commercial e-mail, even permission-based, opt-in e-mail. It is also applicable to B2B e-mail communications and one-to-one commercial e-mail messages such as e-mail from sales representatives to physicians.
Read this article now. It’s FREE…
Download PDF fileWhy Pharma Can’t Ignore eDetailers
This article reviews a presentation by Elizabeth W. Boehm, Forrester Research Analyst in which she presented multiple data sets, including results from Forrester’s Technographics Benchmark Study and eDetailing Survey.
Click Here for Full Text – FREE! (pdf).
YouPharma: New Rules for Pharma Marketing and Social Media
Highlights from a Pharma Roundtable discussion and comments from several bloggers in the Pharma Blogosphere about pharma use of social media.
Order and pay for this reprint now using your credit card…
ONLY $9.95Download PDF file immediately after paying: